Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Modeling glioblastoma complexity with organoids for personalized treatments
Kristen D. Pawlowski, Joseph Duffy, Maria V. Babak, et al.
Trends in Molecular Medicine (2023) Vol. 29, Iss. 4, pp. 282-296
Open Access | Times Cited: 17

Showing 17 citing articles:

Exploring the promising potential of induced pluripotent stem cells in cancer research and therapy
Matin Chehelgerdi, Fereshteh Behdarvand Dehkordi, Mohammad Chehelgerdi, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 68
Personalized Treatment of Glioblastoma: Current State and Future Perspective
Alen Rončević, Nenad Koruga, Anamarija Soldo Koruga, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1579-1579
Open Access | Times Cited: 26
Mitocytosis Mediated by an Enzyme‐Activable Mitochondrion‐Disturbing Polymer‐Drug Conjugate Enhances Active Penetration in Glioblastoma Therapy
Yufan Xiang, Bing Wang, Wanchun Yang, et al.
Advanced Materials (2024) Vol. 36, Iss. 18
Closed Access | Times Cited: 12
Nanoparticles for efficient drug delivery and drug resistance in glioma: New perspectives
Jiyuan Liu, Fan Yang, Jinqu Hu, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 5
Open Access | Times Cited: 11
Human Brain Organoids: Why There Can Be Moral Concerns If They Grow Up in the Lab and Are Transplanted or Destroyed
Andrea Lavazza, Massimo Reichlin
Cambridge Quarterly of Healthcare Ethics (2023) Vol. 32, Iss. 4, pp. 582-596
Open Access | Times Cited: 12
Targeting alternative splicing in cancer immunotherapy
Nan Han, Zhaoqi Liu
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 11
Modelling glioblastoma resistance to temozolomide. A mathematical model to simulate cellular adaptation in vitro
Marina Pérez-Aliacar, Jacobo Ayensa-Jiménez, Teodora Ranđelović, et al.
Computers in Biology and Medicine (2024) Vol. 180, pp. 108866-108866
Open Access | Times Cited: 4
Organoid models: applications and research advances in colorectal cancer
Yijie Wu, Sha Yu, Xingpo Guo, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Evolution of Preclinical Models for Glioblastoma Modelling and Drug Screening
Grace Thomas, Ruman Rahman
Current Oncology Reports (2025)
Open Access
Single-atom nanozymes: classification, regulation strategy, and safety concerns
Jiping Han, Yaohua Gu, Changyi Yang, et al.
Journal of Materials Chemistry B (2023) Vol. 11, Iss. 41, pp. 9840-9866
Closed Access | Times Cited: 9
Translational Models in Glioma Immunotherapy Research
Alexander Ren, Janet Y. Wu, Si Yeon Lee, et al.
Current Oncology (2023) Vol. 30, Iss. 6, pp. 5704-5718
Open Access | Times Cited: 7
A comparison study of dynamic [18F]Alfatide II imaging and [11C]MET in orthotopic rat models of glioblastoma
Yue Pan, Haodan Dang, Haoxi Zhou, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 1
IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Huangyi Ji, Yufei Lan, Pengpeng Xing, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Green synthesis of metal nanocarriers: a perspective for targeting glioblastoma
Taskeen Docrat, Ali O. E. Eltahir, Ahmed A. Hussein, et al.
Drug Discovery Today (2024), pp. 104219-104219
Open Access | Times Cited: 1
The Role of HDAC6 in Glioblastoma Multiforme: A New Avenue to Therapeutic Interventions?
Francesco Spallotta, Barbara Illi
Biomedicines (2024) Vol. 12, Iss. 11, pp. 2631-2631
Open Access | Times Cited: 1
IL-18, a therapeutic target for immunotherapy boosting, promotes temozolomide chemoresistance via the PI3K/AKT pathway in glioma
Huangyi Ji, Yufei Lan, Pengpeng Xing, et al.
Research Square (Research Square) (2024)
Open Access
Nanopolymers and Nanoconjugates for Central Nervous System Diagnostics and Therapies
Cedric Kier Lansangan, Serge Rudensky, Christopher C. Perry, et al.
(2024), pp. 45-55
Closed Access
Page 1

Scroll to top